FDA Approves GSK's Pentavalent Meningococcal Vaccine Dr. Kamal Kant Kohli18 Feb 2025 9:00 PM ISTThe US Food and Drug Administration (FDA) has approved GSK's pentavalent meningococcal vaccine, Penmenvy, for children and young adults aged 10 to 25...
4-component protein-based vaccine highly effective against serogroup B invasive meningococcal disease: JAMA Jacinthlyn Sylvia24 Aug 2023 9:15 AM ISTIn the ongoing efforts to combat serogroup B invasive meningococcal disease (IMD), a recent study revealed promising results regarding the...
GSK declares positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine Ruchika Sharma15 March 2023 5:30 PM ISTLondon: GSK plc has announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity...
